• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为有效的DNA嵌入剂和拓扑异构酶II抑制剂的罗丹宁糖苷衍生物的设计、合成、计算研究及抗肿瘤评价

Design, Synthesis, Computational Investigations, and Antitumor Evaluation of -Rhodanine Glycosides Derivatives as Potent DNA Intercalation and Topo II Inhibition against Cancer Cells.

作者信息

Khodair Ahmed I, Alzahrani Fatimah M, Awad Mohamed K, Al-Issa Siham A, Al-Hazmi Ghaferah H, Nafie Mohamed S

机构信息

Chemistry Department, Faculty of Science, Kafrelsheikh University, 33516 Kafrelsheikh, Egypt.

Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.

出版信息

ACS Omega. 2023 Mar 28;8(14):13300-13314. doi: 10.1021/acsomega.3c00641. eCollection 2023 Apr 11.

DOI:10.1021/acsomega.3c00641
PMID:37065038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10099454/
Abstract

Nitrogen and sulfur glycosylation was carried out via the reaction of rhodanine () with α-acetobromoglucose under basic conditions. Deacetylation of the protected nitrogen nucleoside was performed with CHONa in CHOH without cleavage of the rhodanine ring to afford the deprotected nitrogen nucleoside . Further, deacetylation of the protected sulfur nucleoside was performed with CHONa in CHOH with the cleavage of the rhodanine ring to give the hydrolysis product . The protected nitrogen nucleosides - were produced by condensing the protected nitrogen nucleoside with the aromatic aldehydes - in CHOH while using morpholine as a secondary amine catalyst. Deacetylation of the protected nitrogen nucleosides - was performed with NaOCH/CHOH without cleavage of the rhodanine ring to afford the deprotected nitrogen nucleosides -. NMR spectroscopy was used to designate the anomers' configurations. To examine the electrical and geometric properties derived from the stable structure of the examined compounds, molecular modeling and DFT calculations using the B3LYP/6-31+G (d,p) level were carried out. The quantum chemical descriptors and experimental findings showed a strong connection. The IC values for most compounds were very encouraging when evaluated against MCF-7, HepG2, and A549 cancer cells. Interestingly, IC values for , , and were much lower than those for Doxorubicin (7.67, 8.28, 6.62 μM): (3.7, 8.2, 9.8 μM), (3.1, 13.7, 21.8 μM), and (7.17, 2.2, 4.5 μM), respectively. Against Topo II inhibition and DNA intercalation, when compared to Dox (IC = 9.65 and 31.27 μM), compound showed IC values of 7.3 and 18.2 μM, respectively. In addition, compound induced a 65.6-fold increase in the rate of apoptotic cell death in HepG2 cells, with the cell cycle being arrested in the G2/M phase as a result. Additionally, it upregulated the apoptosis-mediated genes of P53, Bax, and caspase-3,8,9 by 9.53, 8.9, 4.16, 1.13, and 8.4-fold change, while it downregulated the Bcl-2 expression by 0.13-fold. Therefore, glucosylated Rhodanines may be useful as potential therapeutic candidates against cancer because of their topoisomerase II and DNA intercalation activity.

摘要

氮和硫糖基化反应是通过若丹宁()与α - 乙酰溴葡萄糖在碱性条件下反应进行的。用甲醇钠在甲醇中对受保护的氮核苷进行脱乙酰化反应,且不裂解若丹宁环,得到脱保护的氮核苷。此外,用甲醇钠在甲醇中对受保护的硫核苷进行脱乙酰化反应时,若丹宁环会裂解,得到水解产物。受保护的氮核苷 - 是通过在甲醇中,以吗啉作为仲胺催化剂,使受保护的氮核苷与芳香醛 - 缩合制得的。用甲醇钠/甲醇对受保护的氮核苷 - 进行脱乙酰化反应,且不裂解若丹宁环,得到脱保护的氮核苷 - 。利用核磁共振光谱确定端基异构体的构型。为了研究所检测化合物稳定结构衍生出的电学和几何性质,使用B3LYP/6 - 31 + G(d,p)水平进行了分子建模和密度泛函理论计算。量子化学描述符与实验结果显示出紧密联系。当针对MCF - 7、HepG2和A549癌细胞进行评估时,大多数化合物的半数抑制浓度(IC)值非常令人鼓舞。有趣的是,,和的IC值远低于阿霉素的IC值(7.67、8.28、6.62 μM):分别为(3.7、8.2、9.8 μM),(3.1、13.7、21.8 μM)和(7.17、2.2、4.5 μM)。与阿霉素(IC = 9.65和31.27 μM)相比,在拓扑异构酶II抑制和DNA嵌入方面,化合物的IC值分别为7.3和18.2 μM。此外,化合物在HepG2细胞中诱导凋亡细胞死亡率增加了65.6倍,结果细胞周期停滞在G2/M期。此外,它使凋亡介导基因P53、Bax和半胱天冬酶 - 3、8、9上调了9.53、8.9、4.16、1.13和8.4倍,同时使Bcl - 2表达下调了0.13倍。因此,糖基化若丹宁因其拓扑异构酶II和DNA嵌入活性,可能作为潜在的抗癌治疗候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/7babafe8a600/ao3c00641_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/a2003b4eb35e/ao3c00641_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/3a7c74a49fba/ao3c00641_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/1c0c225cb19e/ao3c00641_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/0fe959992112/ao3c00641_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/6450db451564/ao3c00641_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/c07a6940c39b/ao3c00641_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/f38005ca40b6/ao3c00641_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/da78518e3ca7/ao3c00641_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/d9bb538ed9bc/ao3c00641_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/620e8f4c52a9/ao3c00641_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/7babafe8a600/ao3c00641_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/a2003b4eb35e/ao3c00641_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/3a7c74a49fba/ao3c00641_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/1c0c225cb19e/ao3c00641_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/0fe959992112/ao3c00641_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/6450db451564/ao3c00641_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/c07a6940c39b/ao3c00641_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/f38005ca40b6/ao3c00641_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/da78518e3ca7/ao3c00641_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/d9bb538ed9bc/ao3c00641_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/620e8f4c52a9/ao3c00641_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6cd/10099454/7babafe8a600/ao3c00641_0009.jpg

相似文献

1
Design, Synthesis, Computational Investigations, and Antitumor Evaluation of -Rhodanine Glycosides Derivatives as Potent DNA Intercalation and Topo II Inhibition against Cancer Cells.作为有效的DNA嵌入剂和拓扑异构酶II抑制剂的罗丹宁糖苷衍生物的设计、合成、计算研究及抗肿瘤评价
ACS Omega. 2023 Mar 28;8(14):13300-13314. doi: 10.1021/acsomega.3c00641. eCollection 2023 Apr 11.
2
Design, synthesis, molecular modelling and antitumor evaluation of -glucosylated rhodanines through topo II inhibition and DNA intercalation.通过拓扑异构酶 II 抑制和 DNA 嵌入设计、合成、分子模拟及-葡糖苷化罗丹宁类化合物的抗肿瘤活性评价。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2163996. doi: 10.1080/14756366.2022.2163996.
3
New N-ribosides and N-mannosides of rhodanine derivatives with anticancer activity on leukemia cell line: Design, synthesis, DFT and molecular modelling studies.具有抗白血病细胞系活性的罗丹宁衍生物的新型 N-核苷和 N-甘露糖苷:设计、合成、DFT 和分子模拟研究。
Carbohydr Res. 2020 Jan;487:107894. doi: 10.1016/j.carres.2019.107894. Epub 2019 Dec 14.
4
Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.与肟和硝酸盐部分相连的吡唑衍生物作为一氧化氮供体选择性COX-2和芳香化酶抑制剂的设计、合成、模型研究及生物学评价,具有双重抗炎和抗肿瘤活性。
Bioorg Chem. 2023 May;134:106428. doi: 10.1016/j.bioorg.2023.106428. Epub 2023 Feb 18.
5
Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition.新型基于吡唑的COX-2抑制剂作为潜在抗癌剂:设计、合成、对耐药癌细胞的细胞毒性作用、细胞周期阻滞、凋亡诱导及双重EGFR/Topo-1抑制
Bioorg Chem. 2023 Feb;131:106273. doi: 10.1016/j.bioorg.2022.106273. Epub 2022 Nov 14.
6
Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors.新型酞嗪衍生物作为潜在 DNA 嵌入剂和拓扑异构酶 II 抑制剂的设计、合成、分子模拟、体内研究和抗癌活性评价。
Bioorg Chem. 2020 Oct;103:104233. doi: 10.1016/j.bioorg.2020.104233. Epub 2020 Aug 26.
7
Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.苯丙氨酸衍生的(Z)-5-芳基亚甲基硫代罗丹宁对金黄色葡萄球菌DNA促旋酶和拓扑异构酶IV活性的双重抑制作用
Bioorg Med Chem. 2015 Sep 15;23(18):6125-37. doi: 10.1016/j.bmc.2015.08.004. Epub 2015 Aug 14.
8
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors.发现新型三唑并酞嗪衍生物作为 DNA 嵌入剂和拓扑异构酶 II 抑制剂。
Arch Pharm (Weinheim). 2021 Jun;354(6):e2000456. doi: 10.1002/ardp.202000456. Epub 2021 Feb 8.
9
Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.设计、合成、分子对接及[1,2,4]三唑并[4,3-a]喹喔啉衍生物作为 DNA 嵌入剂和拓扑异构酶 II 抑制剂的抗增殖活性评价。
Bioorg Chem. 2020 Dec;105:104399. doi: 10.1016/j.bioorg.2020.104399. Epub 2020 Oct 21.
10
A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.一种新型拓扑异构酶II抑制剂的合理设计策略,用于合成具有抗肿瘤活性的4-O-(2-吡嗪羧酸)-4'-去甲基表鬼臼毒素,通过减少拓扑异构酶II-DNA解连环的松弛反应来实现。
Bioorg Med Chem. 2014 Jun 1;22(11):2998-3007. doi: 10.1016/j.bmc.2014.03.048. Epub 2014 Apr 13.

引用本文的文献

1
Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential.新型合成色烯对脂肪细胞分化和脂质代谢的调控:探索抗肥胖及更广泛的治疗潜力
Sci Rep. 2025 Feb 3;15(1):4051. doi: 10.1038/s41598-025-87945-1.

本文引用的文献

1
Design, synthesis, molecular modelling and antitumor evaluation of -glucosylated rhodanines through topo II inhibition and DNA intercalation.通过拓扑异构酶 II 抑制和 DNA 嵌入设计、合成、分子模拟及-葡糖苷化罗丹宁类化合物的抗肿瘤活性评价。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2163996. doi: 10.1080/14756366.2022.2163996.
2
Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer.通过设计与合成新型烷基化吲哚基 - 三唑席夫碱靶向乳腺癌来探索新型血管内皮生长因子受体2(VEGFR2)酪氨酸激酶抑制剂
Bioorg Chem. 2022 May;122:105708. doi: 10.1016/j.bioorg.2022.105708. Epub 2022 Mar 8.
3
Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and studies.
新型基于邻苯二甲酰亚胺的衍生物作为有效的抗癌药物对拓扑异构酶 II 的抑制和 DNA 嵌入作用:设计、合成、抗增殖、对接和研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):299-314. doi: 10.1080/14756366.2021.2007905.
4
Novel -Thiazole Derivatives: Synthesis and Potential Cytotoxic Activity Through Apoptosis With Molecular Docking Approaches.新型噻唑衍生物:通过分子对接方法诱导凋亡的合成及潜在细胞毒性活性
Front Chem. 2021 Aug 12;9:694870. doi: 10.3389/fchem.2021.694870. eCollection 2021.
5
Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity.设计、合成及评价新型喹唑啉-4-酮衍生物作为具有强抗肿瘤活性的凋亡增强剂和自噬抑制剂。
Eur J Med Chem. 2021 Oct 15;222:113609. doi: 10.1016/j.ejmech.2021.113609. Epub 2021 Jun 5.
6
Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction: In vitro, in vivo, and in silico integrated approaches.新型取代吡啶衍生物的合成及其作为诱导细胞凋亡的肝癌治疗药物的研究:体外、体内及基于计算的综合研究方法。
Bioorg Chem. 2021 Jun;111:104877. doi: 10.1016/j.bioorg.2021.104877. Epub 2021 Mar 29.
7
Synthesis, antiviral, DFT and molecular docking studies of some novel 1,2,4-triazine nucleosides as potential bioactive compounds.合成、抗病毒、DFT 和分子对接研究新型 1,2,4-三嗪核苷作为潜在的生物活性化合物。
Carbohydr Res. 2021 Feb;500:108246. doi: 10.1016/j.carres.2021.108246. Epub 2021 Jan 22.
8
Chemical Profiling, Antioxidant, Cytotoxic Activities and Molecular Docking Simulation of DC. (Cruciferae).十字花科菘蓝属植物的化学特征分析、抗氧化、细胞毒性活性及分子对接模拟
Antioxidants (Basel). 2020 Dec 16;9(12):1286. doi: 10.3390/antiox9121286.
9
Cytotoxicity, predictions and molecular studies for androstane heterocycle compounds revealed potential antitumor agent against lung cancer cells.细胞毒性、预测和分子研究表明雄烷杂环化合物是一种有潜力的肺癌细胞抗肿瘤药物。
J Biomol Struct Dyn. 2022 Jul;40(10):4352-4365. doi: 10.1080/07391102.2020.1856188. Epub 2020 Dec 10.
10
Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells.发现新型吡唑并[3,4-b]吡啶骨架衍生物作为乳腺癌 MCF-7 细胞中潜在的 PIM-1 激酶抑制剂。
Bioorg Med Chem. 2020 Dec 15;28(24):115828. doi: 10.1016/j.bmc.2020.115828. Epub 2020 Nov 2.